SCHEMBL7701562

SCHEMBL7701562

CCN(CC)CCNC(=O)CCCOc1cccc(-c2n[nH]c3c2Cc2ccccc2-3)c1

nearest known ligand 0.44

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
KDR P35968 8/20 0.44
CHEK1 O14757 5/20 0.41
AURKA O14965 1/20 0.40
CHEK2 O96017 1/20 0.40
LCK P06239 1/20 0.40
CSF1R P07333 1/20 0.40
FGFR1 P11362 1/20 0.40
MARK3 P27448 1/20 0.40
FLT3 P36888 1/20 0.40
ITK Q08881 1/20 0.40
MARK2 Q7KZI7 1/20 0.40
AURKB Q96GD4 1/20 0.40
CDK1 P06493 1/20 0.40
CDK2 P24941 1/20 0.40
HPGD P15428 1/20 0.39
HIF1A Q16665 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
ATG4B Q9Y4P1 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7090440 0.93 KDR (0.46) KDRCHEK1LCKCSF1RFLT3
SCHEMBL7703314 0.87 KDR (0.53) KDRCHEK1MARK3FLT3MARK2
SCHEMBL7136211 0.86 KDR (0.54) KDRCHEK1MARK3FLT3MARK2
SCHEMBL6997182 0.82 CHEK1 (0.51) KDRCHEK1AURKACHEK2LCK
SCHEMBL7090918 0.82 KDR (0.58) KDRCHEK1CDK1CDK2HIF1A
SCHEMBL6995193 0.82 KDR (0.55) KDRCHEK1AURKACHEK2LCK
SCHEMBL7090397 0.81 KDR (0.50) KDRCHEK1LCKCSF1RFLT3
SCHEMBL7702681 0.81 KDR (0.52) KDRCHEK1CDK1CDK2HIF1A
SCHEMBL7702724 0.80 KDR (0.53) KDRCHEK1MARK3FLT3MARK2
SCHEMBL7700936 0.80 KDR (0.55) KDRCHEK1CDK1CDK2HIF1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1127051-A2 TRICYCLIC PYRAZOLE DERIVATIVES BASF AKTIENGESELLSCHAFT (DE) 2001-08-29 EP claimed
WO-2000027822-A2 TRICYCLIC PYRAZOLE DERIVATIVES BASF AKTIENGESELLSCHAFT (DE) 2000-05-18 WO claimed
US-6462036-B1 INHIBITING SIGNAL TRANSDUCTION BY MODULATING ACTIVITY OF RECEPTOR AND NONRECEPTOR TYROSINE AND SERINE/THREONINE KINASES TO REGULATE AND MODULATE ABNORMAL OR INAPPROPRIATE CELL PROLIFERATION, DIFFERENTIATION, OR METABOLISM BASF AKTIENGESELLSCHAFT (DE) 2002-10-08 US disclosed
EP-1127051-A2 TRICYCLIC PYRAZOLE DERIVATIVES BASF AKTIENGESELLSCHAFT (DE) 2001-08-29 EP disclosed
WO-2000027822-A2 TRICYCLIC PYRAZOLE DERIVATIVES BASF AKTIENGESELLSCHAFT (DE) 2000-05-18 WO disclosed